Fiduciary Trust CO Global Blood Therapeutics, Inc. Transaction History

Fiduciary Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $125 - $261	-3 Reduced 0.03%	11,550 $590,000
Q3 2019 Nov 12, 2019	BUY	$45.35 - $57.91 $136 - $173	3 Added 0.03%	11,553 $561,000
Q1 2019 May 07, 2019	SELL	$39.99 - $53.48 $399,900 - $534,800	-10,000 Reduced 46.4%	11,550 $611,000
Q1 2018 May 08, 2018	SELL	$39.6 - $65.9 $239,738 - $398,958	-6,054 Reduced 21.93%	21,550 $1.04 Million
Q4 2017 Jan 29, 2018	BUY	$29.7 - $45.7 $119,512 - $183,896	4,024 Added 17.07%	27,604 $1.09 Million
Q3 2017 Nov 02, 2017	BUY	$25.1 - $31.05 $591,858 - $732,159	23,580	23,580 $732,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

Stay updated on Fiduciary Trust CO with notifications on news.